ELUVIA™

Drug-Eluting Vascular Stent System

The Eluvia Drug-Eluting Stent System continues to demonstrate unprecedented clinical outcomes with a 92.5% freedom from TLR at 2 years, the highest reported in comparable SFA clinical trials.

Key Resources

Resource Download Center Eluvia Stent Ordering Information
Anchor component is added but not authored

Product Details

product details for Eluvia Drug Eluting Vascular Stent System product details for Eluvia Drug Eluting Vascular Stent System

  

An innovative treatment option that sustains drug release beyond one year to deliver unprecedented clinical outcomes in the SFA.

Ordering Information

Eluvia Size Chart Eluvia Size Chart

Description UPN
Eluvia 6mm x 40mm x 75cm H74939295600470
Eluvia 6mm x 60mm x 75cm H74939295600670
Eluvia 6mm x 80mm x 75cm H74939295600870
Eluvia 6mm x 100mm x 75cm H74939295601070
Eluvia 6mm x 120mm x 75cm H74939295601270
Eluvia 6mm x 150mm x 75cm H74939295601570
Eluvia 7mm x 40mm x 75cm H74939295700470
Eluvia 7mm x 60mm x 75cm H74939295700670
Eluvia 7mm x 80mm x 75cm H74939295700870
Eluvia 7mm x 100mm x 75cm H74939295701070
Eluvia 7mm x 120mm x 75cm H74939295701270
Eluvia 7mm x 150mm x 75cm H74939295701570
Eluvia 6mm x 40mm x 130cm H74939295600410
Eluvia 6mm x 60mm x 130cm H74939295600610
Eluvia 6mm x 80mm x 130cm H74939295600810
Eluvia 6mm x 100mm x 130cm H74939295601010
Eluvia 6mm x 120mm x 130cm H74939295601210
Eluvia 6mm x 150mm x 130cm H74939295601510
Eluvia 7mm x 40mm x 130cm H74939295700410
Eluvia 7mm x 60mm x 130cm H74939295700610
Eluvia 7mm x 80mm x 130cm H74939295700810
Eluvia 7mm x 100mm x 130cm H74939295701010
Eluvia 7mm x 120mm x 130cm H74939295701210
Eluvia 7mm x 150mm x 130cm H74939295701510

See UPN Product Codes

Clinical Information

MAJESTIC Clinical Trial

 

 

Majestic Trial 12-month Results Rutherford Category for ELUVIA SFA drug-eluting stents (DES). Majestic Trial 12-month Results Rutherford Category for ELUVIA SFA drug-eluting stents (DES).

  • 91% of patients presented with no or minimal claudication at 2 years
  • 91% of patients sustained clinical improvement through 2 years
  • ABI improvement sustained through 2 years (0.94±0.22)

  

Related Technologies

Top